Does Mounjaro Make You Burn More Calories — or Just Eat Fewer?

What SURMOUNT-1 tells us about how the weight comes off

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and no diabetes and followed them for 72 weeks. At the highest dose, participants lost around 20–21% of their body weight on average. Crucially, analysis of how that weight was lost points squarely at reduced energy intake, not increased energy expenditure. Tirzepatide activates both GIP and GLP-1 receptors (the only licensed weight-loss medicine in the UK to do so) and both pathways act on the brain's appetite centres to dampen hunger and reduce food reward. Gastric emptying also slows, so a smaller meal feels more substantial for longer.

What tirzepatide does not appear to do, in any robust way, is switch your cells into a higher gear. Resting metabolic rate is tightly controlled by thyroid hormones, lean body mass, and genetics. No current evidence from the SURMOUNT programme suggests tirzepatide overrides those controls. The calorie deficit that drives the weight loss is almost entirely a consequence of eating less, not burning more. That is not a limitation (a 20% average body-weight reduction is extraordinary by any clinical measure) but it does have practical implications for how you eat during treatment.

You can read more about how daily calorie targets shift on tirzepatide on our calories on Mounjaro page.

Why your total energy expenditure still changes, just not the way you might expect

Here is where it gets interesting. Metabolic rate is not a fixed number. As your body mass falls, your total daily energy expenditure falls with it, a smaller body needs fewer calories to function. This is sometimes called adaptive thermogenesis, and it is one reason weight loss naturally slows over time even when nothing about your behaviour has changed. Mounjaro does not prevent this adaptation; it works within the same biology everyone else does.

There is, however, one indirect route through which tirzepatide may support a better metabolic outcome: body composition. Trial data suggests a meaningful proportion of weight lost on tirzepatide is fat mass rather than lean muscle, particularly when protein intake is adequate and resistance activity is maintained. Since muscle is more metabolically active than fat, protecting lean mass during weight loss helps preserve resting energy expenditure as much as possible. This is not a calorie-burning boost from the medicine itself, it is the result of losing weight in a way that spares muscle. Our guide to eating well on Mounjaro covers protein targets and practical food choices in more detail.

The NHS tirzepatide information page notes that the medicine works alongside a reduced-calorie diet and increased physical activity, that framing is deliberate. The medicine creates the appetite conditions; the lifestyle work protects your muscle and long-term metabolic health.

Practical implications: how many calories do you actually need on treatment?

Because appetite falls substantially (sometimes dramatically in the early weeks) many people on tirzepatide end up eating far less than they realise. The risk is not eating too much; it is occasionally eating too little, particularly of protein. If meals shrink to very small portions, the body can start drawing on muscle as well as fat for energy, which undermines the body-composition advantage described above.

There is no single calorie target that works for everyone on Mounjaro. Your size, age, sex, activity level and how your body responds to titration all feed into what is appropriate. Our page on how many calories to eat on Mounjaro walks through the general principles, and our daily calorie guidance page looks at how to think about intake as doses change. Both are starting points, not prescriptions, specific targets are for your prescriber or a dietitian to advise on.

One thing worth knowing: some people notice physical changes they weren't expecting, including increased perspiration during early dose increases. If that is on your mind, our page on sweating and Mounjaro explains what is and isn't typical. And if food is tasting differently to you on treatment, the question about Mounjaro and food taste is one our prescribers hear fairly regularly.

So should calorie burning factor into why you choose Mounjaro?

Honestly, no, not as a primary reason. The case for tirzepatide rests on its appetite-regulating effects and the resulting sustained calorie reduction, backed by some of the strongest weight-management trial evidence available. If a treatment or article promises that a GLP-1 medicine will "rev up your metabolism" or burn fat directly, treat that claim with scepticism.

What Mounjaro does offer is a clinically evidenced way to eat less, more comfortably, over a sustained period, and for many people that is the hardest part. Questions about cost are reasonable too; our Mounjaro pricing page sets out what private treatment typically involves. Mounjaro is a prescription-only medicine, so suitability is assessed by a clinician, not determined by BMI alone or any online calculator. If you want to understand whether it might be right for you, the right next step is a clinical conversation.

Check your eligibility and start a free consultation with our team at nume's weight-loss treatments page.